- Home
- MDBH vs CCEL Comparison
MDBH vs CCEL Comparison
Compare MDBH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- CCEL
- Stock Information
- Founded
- MDBH 1997
- CCEL 1989
- Country
- MDBH United States
- CCEL United States
- Employees
- MDBH N/A
- CCEL N/A
- Industry
- MDBH
- CCEL Managed Health Care
- Sector
- MDBH
- CCEL Health Care
- Exchange
- MDBH Nasdaq
- CCEL Nasdaq
- Market Cap
- MDBH 38.2M
- CCEL 34.8M
- IPO Year
- MDBH 2023
- CCEL 1997
- Fundamental
- Price
- MDBH N/A
- CCEL $4.53
- Analyst Decision
- MDBH
- CCEL Strong Buy
- Analyst Count
- MDBH 0
- CCEL 1
- Target Price
- MDBH N/A
- CCEL $8.50
- AVG Volume (30 Days)
- MDBH 13.3K
- CCEL 19.7K
- Earning Date
- MDBH 11-11-2025
- CCEL 10-15-2025
- Dividend Yield
- MDBH N/A
- CCEL 13.39%
- EPS Growth
- MDBH N/A
- CCEL N/A
- EPS
- MDBH 0.56
- CCEL N/A
- Revenue
- MDBH N/A
- CCEL $31,988,783.00
- Revenue This Year
- MDBH N/A
- CCEL $1.75
- Revenue Next Year
- MDBH N/A
- CCEL N/A
- P/E Ratio
- MDBH $6.02
- CCEL N/A
- Revenue Growth
- MDBH N/A
- CCEL 1.10
- 52 Week Low
- MDBH $3.16
- CCEL $4.09
- 52 Week High
- MDBH $9.42
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- MDBH 45.38
- CCEL 42.78
- Support Level
- MDBH $3.33
- CCEL $4.39
- Resistance Level
- MDBH $3.55
- CCEL $4.93
- Average True Range (ATR)
- MDBH 0.19
- CCEL 0.12
- MACD
- MDBH 0.00
- CCEL -0.03
- Stochastic Oscillator
- MDBH 40.92
- CCEL 10.98
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.